友成 哲 医師の原著論文がJGH Openに掲載されました。
Tomonari T, Tani J, Sato Y, Tanaka H, Morishita A, Okamoto K, Kawano Y, Sogabe M, Miyamoto H, Takayama T.
Initial treatment efficacy and safety of durvalumab plus tremelimumab combination therapy in unresectable hepatocellular carcinoma in clinical practice.
JGH Open. 2024 Oct 4;8(10):e70033.
Initial treatment efficacy and safety of durvalumab plus tremelimumab combination therapy in unresectable hepatocellular carcinoma in clinical practice.
JGH Open. 2024 Oct 4;8(10):e70033.
doi: 10.1002/jgh3.70033. PMID: 39371045
